Also found in: Dictionary, Thesaurus, Encyclopedia.


Drugs that suppress, delay, or prevent blood clots. Anticoagulants are used to treat embolisms.


agents (warfarin, aspirin, clopidogrel, coumarin, heparin) that prevent or reduce blood coagulation; prescribed to prolong clotting time or prevent intravascular clot formation, e.g. in patients with a history of stroke, ischaemic heart disease, peripheral vascular disease, atrial fibrillation or deep-vein thrombosis; side-effects include prolonged bleeding, easy and excessive bruising; concomitant non-steroidal anti-inflammatory drugs, carbamazepine, antifungal medications, erythromycin, clarithromycin, metronidazole and broad-spectrum oral antibiotics (e.g. amoxicillin) increase anticoagulant effects
References in periodicals archive ?
Designed specifically for use by hospital-based clinicians and associated hospital-based staff, this fully evidence-based book addresses the most commonly used anticoagulant agents, the latest advances in anticoagulation drugs, and primary indications for their use at therapeutic levels.
One of the shortcomings of oral anticoagulants is the lack of a strategy for reversal in case of emergency or uncontrolled bleeding.
The findings also reveal that drug development is not limited to anticoagulants in the atrial fibrillation market.
The Phase IIa proof-of-concept NOVEL study (Neutralizable anticOagulant eValuation in Extracorporeal circuLation) is designed to assess the safety and tolerability of EP217609 compared to heparin in 36 patients undergoing cardiac surgery.
However, they also indicate that such changes in the prescribing of anticoagulants are more likely to occur initially in the private versus the public sector.
Market Dynamics II-8 Drug Advancements Drive Anticoagulant Market II-8 Niche Markets - The New Target for Drug Makers II-8 An Opportunity to Grow Further II-8 Geriatric Patients - At High Risk of Blood Clots II-8 Improved Anticoagulant Agents for Children Group II-9 Growing Demand for Self-Testing II-9 LMWHs Eases Outpatient Management II-9 Concern Over Underutilization of Warfarin II-9 Anticoagulants to Lose UA/AMI Markets to Antiplatelets II-10 Influx of New Drugs: Invigorates the Market II-10 Novel Heparins: Enhances Market Potential II-10 Anticoagulant Therapy During Pregnancy Improves Outcomes II-10 New Therapies: Need of the Hour II-11 Anticoagulant Therapy in IPF: Reduces Mortality Risk II-11 Failure of Exanta II-11
Anticoagulants are vital medicines for treating and preventing blood clots.
The efficacy and safety of treatment, based on the incidence of strokes and of intracranial and gastrointestinal bleeds, were roughly similar in the dabigatran, rivaroxaban, and warfarin subgroups, and the rates for the new anticoagulants also roughly matched the rates seen in the pivotal trials with those drugs, suggesting that the new anticoagulants were performing well when used in octo- and nonagenarians, Dr.
This report provides a thorough overview of these and other new oral anticoagulants, their approved indications, drug profiles, pharmacokinetic parameters and the respective areas of market growth.
Evidence has shown that anticoagulants may interfere with cancer growth and spread," Kevin Choe, lead author of the study and a radiation oncologist at University of Texas Southwestern Medical School in Dallas, said.
Currently, many patients need repeated postoperative injections of anticoagulants such as heparin or related drugs.
The mouse, rat and gopher poisons most commonly available to homeowners at local stores include some of these anticoagulants.

Full browser ?